These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 18702104)

  • 1. Circulating soluble endoglin and placental abruption.
    Signore C; Mills JL; Qian C; Yu KF; Rana S; Karumanchi SA; Levine RJ
    Prenat Diagn; 2008 Sep; 28(9):852-8. PubMed ID: 18702104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Failure of second-trimester measurement of soluble endoglin and other angiogenic factors to predict placental abruption.
    Tikkanen M; Stenman UH; Nuutila M; Paavonen J; Hiilesmaa V; Ylikorkala O
    Prenat Diagn; 2007 Dec; 27(12):1143-6. PubMed ID: 17960788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can changes in angiogenic biomarkers between the first and second trimesters of pregnancy predict development of pre-eclampsia in a low-risk nulliparous patient population?
    Myatt L; Clifton RG; Roberts JM; Spong CY; Wapner RJ; Thorp JM; Mercer BM; Peaceman AM; Ramin SM; Carpenter MW; Sciscione A; Tolosa JE; Saade G; Sorokin Y; Anderson GD;
    BJOG; 2013 Sep; 120(10):1183-91. PubMed ID: 23331974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating Angiogenic Factors and the Risk of Preeclampsia in Systemic Lupus Erythematosus Pregnancies.
    Leaños-Miranda A; Campos-Galicia I; Berumen-Lechuga MG; Molina-Pérez CJ; García-Paleta Y; Isordia-Salas I; Ramírez-Valenzuela KL
    J Rheumatol; 2015 Jul; 42(7):1141-9. PubMed ID: 25979720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alteration of serum soluble endoglin levels after the onset of preeclampsia is more pronounced in women with early-onset.
    Hirashima C; Ohkuchi A; Matsubara S; Suzuki H; Takahashi K; Usui R; Suzuki M
    Hypertens Res; 2008 Aug; 31(8):1541-8. PubMed ID: 18971528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating angiogenic factors and placental abruption.
    Signore C; Mills JL; Qian C; Yu K; Lam C; Epstein FH; Karumanchi SA; Levine RJ
    Obstet Gynecol; 2006 Aug; 108(2):338-44. PubMed ID: 16880304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble fms-like tyrosine kinase-1 and soluble endoglin in HIV-associated preeclampsia.
    Govender N; Naicker T; Rajakumar A; Moodley J
    Eur J Obstet Gynecol Reprod Biol; 2013 Sep; 170(1):100-5. PubMed ID: 23806447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiogenic biomarkers for prediction of early preeclampsia onset in high-risk women.
    Moore Simas TA; Crawford SL; Bathgate S; Yan J; Robidoux L; Moore M; Maynard SE
    J Matern Fetal Neonatal Med; 2014 Jul; 27(10):1038-48. PubMed ID: 24066977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Serum soluble Endoglin, plasma endothelin-1 and coagulation function in early onset severe preeclampsia with organ dysfunction].
    Zhang LJ; Han YH; Han YZ
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2010 Jun; 22(6):371-4. PubMed ID: 20594474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longitudinal changes in maternal soluble endoglin and angiopoietin-2 in women at risk for pre-eclampsia.
    Khalil A; Maiz N; Garcia-Mandujano R; Elkhouli M; Nicolaides KH
    Ultrasound Obstet Gynecol; 2014 Oct; 44(4):402-10. PubMed ID: 24913462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soluble endoglin for the prediction of preeclampsia in a high risk cohort.
    Maynard SE; Moore Simas TA; Bur L; Crawford SL; Solitro MJ; Meyer BA
    Hypertens Pregnancy; 2010; 29(3):330-41. PubMed ID: 20670156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationship between circulating endothelin-1, soluble fms-like tyrosine kinase-1 and soluble endoglin in preeclampsia.
    Aggarwal PK; Chandel N; Jain V; Jha V
    J Hum Hypertens; 2012 Apr; 26(4):236-41. PubMed ID: 21451568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of angiogenic biomarkers in maternal blood to identify which SGA fetuses will require a preterm delivery and mothers who will develop pre-eclampsia.
    Chaiworapongsa T; Romero R; Whitten AE; Korzeniewski SJ; Chaemsaithong P; Hernandez-Andrade E; Yeo L; Hassan SS
    J Matern Fetal Neonatal Med; 2016; 29(8):1214-28. PubMed ID: 26303962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maternal plasma soluble endoglin at 11-13 weeks' gestation in pre-eclampsia.
    Foidart JM; Munaut C; Chantraine F; Akolekar R; Nicolaides KH
    Ultrasound Obstet Gynecol; 2010 Jun; 35(6):680-7. PubMed ID: 20205159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble fms-Like tyrosine kinase 1 (sFlt1), endoglin and placental growth factor (PlGF) in preeclampsia among high risk pregnancies.
    Powers RW; Jeyabalan A; Clifton RG; Van Dorsten P; Hauth JC; Klebanoff MA; Lindheimer MD; Sibai B; Landon M; Miodovnik M;
    PLoS One; 2010 Oct; 5(10):e13263. PubMed ID: 20948996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First-trimester serum levels of soluble endoglin and soluble fms-like tyrosine kinase-1 as first-trimester markers for late-onset preeclampsia.
    Baumann MU; Bersinger NA; Mohaupt MG; Raio L; Gerber S; Surbek DV
    Am J Obstet Gynecol; 2008 Sep; 199(3):266.e1-6. PubMed ID: 18771978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulatory soluble endoglin and its predictive value for preeclampsia in second-trimester pregnancies with abnormal uterine perfusion.
    Stepan H; Geipel A; Schwarz F; Krämer T; Wessel N; Faber R
    Am J Obstet Gynecol; 2008 Feb; 198(2):175.e1-6. PubMed ID: 18226617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An imbalance between angiogenic and anti-angiogenic factors precedes fetal death in a subset of patients: results of a longitudinal study.
    Romero R; Chaiworapongsa T; Erez O; Tarca AL; Gervasi MT; Kusanovic JP; Mittal P; Ogge G; Vaisbuch E; Mazaki-Tovi S; Dong Z; Kim SK; Yeo L; Hassan SS
    J Matern Fetal Neonatal Med; 2010 Dec; 23(12):1384-99. PubMed ID: 20459337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gestational angiogenic biomarker patterns in high risk preeclampsia groups.
    Maynard SE; Crawford SL; Bathgate S; Yan J; Robidoux L; Moore M; Moore Simas TA
    Am J Obstet Gynecol; 2013 Jul; 209(1):53.e1-9. PubMed ID: 23517919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alterations of serum and placental endoglin in pre-eclampsia.
    Fang M; He Y; Li H; Wu M; Shi X; Du H
    J Int Med Res; 2010; 38(1):43-51. PubMed ID: 20233512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.